Glaxo Wellcome divests OTCs to Warner-Lambert, puts Greenville, N.C. facility up for sale.
GLAXO WELLCOME PUTS GREENVILLE, N.C. PLANT UP FOR SALE; EXITING OTC BUSINESS with sale of the former Wellcome over-the-counter product line to Warner-Lambert. Glaxo Wellcome announced Dec. 19 that it is divesting its interest in the Warner-Wellcome joint venture for $1.05 bil. in cash. As a result of that divestiture, Glaxo Wellcome will be in a position to dispose of the former Burroughs Wellcome manufacturing facility in Greenville.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth